- 215
- 0
- 约4万字
- 约 14页
- 2021-11-05 发布于江苏
- 举报
欧盟GMP 附录15 确认和验证
欧盟GMP 附录15 确认和验证
欧盟 GMP 附录 15 确认和验证
欧盟 GMP 附录 15 确认和验证
ANNEX 15 附件 15
ANNEX 15 附件 15
Qualification and Validation
Qualification and Validation
确认和验证
确认和验证
Table of Contents 目录
Table of Contents 目录
1. Qualification and Validation 确认和验证
1. Qualification and Validation 确认和验证
2. Planning for Validation 验证计划
2. Planning for Validation 验证计划
3. Documentation 文件
3. Documentation 文件
4. Qualification 确认
4. Qualification 确认
5. Process Validation 工艺验证
5. Process Validation 工艺验证
6. Cleaning Validation 清洁验证
6. Cleaning Validation 清洁验证
7. Change Control 变更控制
7. Change Control 变更控制
8. Revalidation 再验证
8. Revalidation 再验证
9. Glossary 术语表
9. Glossary 术语表
Qualification and Validation 确认和验证
Qualification and Validation 确认和验证
Principle 原理
Principle 原理
1.This Annex describes the principles of qualification and validation which are
1.This Annex describes the principles of qualification and validation which are
applicable to the manufacture of medicinal products. It is a requirement of GMP
applicable to the manufacture of medicinal products. It is a requirement of GMP
that manufacturers identify what validation work is needed to prove control of
that manufacturers identify what validation work is needed to prove control of
the critical aspects of their particular operations. Significant changes to the
the critical aspects of their particular operations. Significant changes to the
facilities, the equipment and the processes, which may affect the quality of
facilities, the equipment and the processes, which may affect the quality of
the product, should be validated. A risk assessment approach should be used to
the product, should be validated. A risk assessment approach should be used to
determine the scope and extent of validation.
determine the scope and extent of validation.
1.本附件描述了确认和验证的原理,适用于医药产品的生产者。这是GMP指导生产者明
1.本附件描述了确认和验证的原理,适用于医药产品的生产者。这是GMP指导生产者明
原创力文档

文档评论(0)